110
Views
17
CrossRef citations to date
0
Altmetric
Perspective

Diabetic retinopathy: the unmet needs for screening and a review of potential solutions

Pages 301-313 | Published online: 09 Jan 2014

References

  • The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States.Arch. Ophthalmol.122, 477–485 (2004).
  • American Diabetes Association PS. Implications of the diabetes control and complications trial.Clin. Diabetes11, 91–96 (1993).
  • Klein R, Klein B. Vision disorders in diabetes. In:Diabetes in America, Second Edition. Group NDD (Ed.), NIH publication, MD, USA, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 95–1468 (1995).
  • Williams R. Diabetes mellitus. In:Health Care Needs Assessment. Stevens A, Raftery J (Eds), Oxford University Press, Oxford, UK, 31–57 (1994).
  • Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1.Arch. Ophthalmol.103, 1796–1806 (1985).
  • Klein R. Barriers to prevention of vision loss caused by diabetic retinopathy.Arch. Ophthalmol.115, 1073–1074 (1997).
  • Agardh E, Arardh C-D, Hansson-Lundblad C. The 5-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy.Diabet. Med.10, 555–559 (1993).
  • Porta M, Bruno G, Pietragalla G et al. Decreasing incidence of diabetes-related blindness in working age in the province of Turin. Age-period-cohort analysis of temporal trends in 1968–97.Diabetologia44, 187 (2001).
  • Kristinsson J. Diabetic retinopathy: screening and prevention of blindness.Acta Ophthalmol. Scand.75, 3–76 (1997).
  • Sjolie A, Greene A. Blindness in insulin-treated diabetic patients with age at onset <30 years.J. Chronic Dis.40, 215–220 (1987).
  • Javitt JC, Canner JC, Frank RG, Steinwachs DM, Sommer A. Detecting and treating retinopathy in patients with type 1 diabetes mellitus: a health policy model.Ophthalmology97, 483–495 (1990).
  • Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type 1 diabetics.Ophthalmology96, 255–264 (1989).
  • Klein R, Moss S, Klien B. New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulation.Diabetes Care10, 633–638 (1987).
  • Abu El Asrar A, Al-Rubeaan K, Al-Amro S, Moharram O, Kangave D. Retinopathy as a predictor of other diabetic complications.Int. Ophthalmol.24, 1–11 (2002).
  • Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy.Ophthalmology88, 583 (1981).
  • Sinclair S, Delvecchio C, Malamut R, Li W. Diabetic retinopathy: treating systemic conditions aggressively can save sight.Cleve. Clin. J. Med.72, 447–454 (2005).
  • Schoenfeld E, Greene J, Wu S, Leske M. Patterns of adherence of diabetes vision care guidelines.Ophthalmology108, 563–571 (2001).
  • Brechner R, Cowie C, Howie L et al. Ophthalmic examination among adults with diagnosed diabetes mellitus.JAMA270, 1714–1718 (1993).
  • Wieiner J, Parente S, Garnick D et al. Variation in office-based quality: a claim-based profile of care provided to Medicare patients with diabetes.JAMA273, 1503–1508 (1995).
  • Moss S, Klein R, Klein B. Factors associated with having eye examinations in persons with diabetes.Arch. Fam. Med.4, 529–534 (1995).
  • Mukamel D, Bresnick G, Wang Q, Dickey C. Barriers to compliance with screening guidelines for diabetic retinopathy.Ophthalmic Epidemiol.6, 61–72 (1999).
  • McCarty C, Lloyd-Smith C, Lee S et al. Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project.Br. J. Ophthalmol.82, 410–414 (1998).
  • Witkin S, Klein R. Ophthalmologic care for persons with diabetes.JAMA251, 2534–2537 (1984).
  • Kinyoun J, Barton F, Fisher M, Hubbard L, Aiello L, Ferris F III. Detection of diabetic macular edema. Ophthalmoscopy versus photography – early treatment diabetic retinopathy study report number 5.Ophthalmology96, 746–751 (1989).
  • Kraft S, Marrero D, Lazaridis E et al. Primary care physicians’ practice patterns and diabetic retinopathy: current levels of care.Arch. Fam. Med.6, 29–37 (1997).
  • Jacques C, Jones R, Houts P et al. Reported practice behaviors for medical care of patients with diabetes mellitus by primary-care physicians in Pennsylvania.Diabetes Care14, 712–717 (1991).
  • Wender R. Preventive health care for diabetics: a realistic vision.Arch. Fam. Med.6, 38–41 (1997).
  • Steinmann W, Sinclair S, Holmes J et al. Retinopathy in diabetics at first ophthalmologic visit.Invest. Ophthalmol. Vis. Sci.27, 4 (1986).
  • Trento M, Bajardi M, Borgo E et al. Perceptions of diabetic retinopathy and screening procedures among diabetic people.Diabet. Med.19, 810–813 (2002).
  • Will J, German R, Schurman E et al. Patient adherence to guidelines for diabetes eye care: results from the diabetic eye disease follow-up study.Am. J. Public Health84, 1669–1671 (1990).
  • Sussman E, Tsiaras W, Soper K. Diagnosis of diabetic eye disease.JAMA247, 3231–3234 (1982).
  • Jacobs D. Teaching doctors about the eye: trends in the education of medical students an primary care residents.Surv. Ophthalmol.42, 383–389 (1998).
  • O’Hare J, Hopper A, Madhaven C et al. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care.BMJ312, 679–682 (1996).
  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the Modified Airlie House Classification: ETDRS report number 10.Ophthalmology98, 786–806 (1991).
  • LinDY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity of single-field nonmydriatic mono-chromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with opthalmoscopy and standardized mydriatic color photography.Am. J. Ophthalmol.134, 204–213 (2002).
  • Lim J, LaBree L, Nicholes T, Gardenas I. A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy.Ophthalmology107, 866–976 (2000).
  • Gomez-Ulla F, Fernandez M, Gonzalez F et al. Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy.Diabetes Care25, 1384–1389 (2002).
  • Bursell S, Cavallerano J, Carallerano A et al. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy.Ophthalmology108, 572–585 (2001).
  • Miszalok V. Chapter 26 fundus imaging and diagnostic screening for public health. In:Noninvasive Diagnostic Techniques in Ophthalmology. Masters BR (Ed.), Springer-Verlag, NY, USA, 510–514 (1990).
  • Zeimer R, Zou S, Meeder T, Quinn K, Vitale S. A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician’s office.Invest. Ophthalmol. Vis. Sci.43, 1581–1587 (2002).
  • Rehkopf PG, Warnicki JW. Ophthalmic image processing. In:Non-Evasive Diagnostic Techniques and Ophthalmology. Masters BR (Ed.) Springer Verlag, NY, USA, 1–16 (1990).
  • Kalm H, Egertsen R, Blohme G. Non-stereo fundus photography as a screening procedure for diabetic retinopathy among patients with type II diabetes compared with 60D enhanced slit-lamp examination.Acta Ophthalmol. (Copenh.)67, 546–553 (1989).
  • Moss S, Klein R, Kressler S, Richie K. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy.Ophthalmology92, 62–67 (1985).
  • Harding S, Broadbent D, Neoh C, White M, Vora J. Sensitivity ad specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study.Br. J. Med.311, 1131–1135 (1995).
  • Schaudig U, Glaefke C, Scholz F, Richard G. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema.Ophthalmic Surg. Lasers31, 182–186 (2000).
  • Williams G, Scott I, Haller J, Maguire A, Marcus D, McDonald H. Single-field fundus photography for diabetic retinopathy screening – a report by the American Academy of Ophthalmology.Ophthalmology111, 1055–1062 (2004).
  • Pugh J, Jacobson J, Van Heuven W et al. Screening for diabetic retinopathy. The wide-angle retinal camera.Diabetes Care16, 889–895 (1993).
  • Joannou J, Kalk W, Mahomed I et al. Screening for diabetic retinopathy in South Africa with 60 degrees retinal colour photography.J. Intern. Med.236, 43–47 (1996).
  • Bailey I, Bullimore M, Raasch T, Taylor H. Clinical grading and the effects of scaling.Invest. Ophthalmol. Vis. Sci.32, 422–432 (1991).
  • Goldbaum M, Chatterjee S, Chaudhuri S, Katz N. Digital image processing for ophthalmology. In:Noninvasive Diagnostic Techniques in Ophthalmology. Masters BR (Ed.), Springer-Verlag, NY, 548–568 (1990).
  • Bhasin S, Sinclair SH, Resnick J, Uzzaman S. Automated computer system grading of diabetic retinopathy from fundus photographs.Arch. Ophthalmol. (In press).
  • Grunwald J, Riva C, Baine J, Brucker A. Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control.Invest. Ophthalmol. Vis. Sci.33, 356–363 (1992).
  • Skovborg F, Nielsen A, Lauritzen E, Hartkopp O. Diameters of the retinal vessels in diabetic and normal subjects.Diabetes18, 292–298 (1969).
  • Wong T, Klein R, Sharrett A et al. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons.JAMA287, 2528–2533 (2002).
  • Nishiwaki H, Shahidi M, Vitale S et al. Relation between retinal thickening and clinically visible fundus pathologies in mild nonproliferative diabetic retinopathy.Ophthalmic Surg. Lasers33, 127–134 (2002).
  • Spaeth GL, Varma R, Hanau C et al. Optic disc vessel shift in glaucoma: image analysis versus clinical evaluation.Invest. Ophthalmol. Vis. Sci.28, 1288 (1987).
  • Riva C, Grunwald J, Sinclair S. Laser dopler velocimetry study of the effects of pure oxygen breathing on retinal blood flow.Invest. Ophthalmol. Vis. Sci.24, 47–51 (1983).
  • Grunwald JE, Riva CE, Brucker AJ, Sinclair SH, Petrig BL. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus.Ophthalmology91, 1447 (1984).
  • Rassam S, Patel V, Kohner E. The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy.Exp. Physiol.80, 53–68 (1995).
  • Grunwald J, Riva C, Brucker A, Sinclair S, Petrig B. Effect of panretinal photocoagulation on retinal blood flow in proliferative diabetic retinopathy.Ophthalmology93, 590–595 (1986).
  • Novack RL, Stefansson E. Measurement of retina and optic nerve oxidative metabolism in vivo via dual wavelength reflection spectrofluorometry of cytochrome a, a3. In:Noninvasive Diagnostic Techniques in Ophthalmology. Masters BR (Ed.), Springer-Verlag, NY, USA, 499–509 (1990).
  • Yang Y, Zou S, Zeimer R, Bressler N, Schachat A, Finkelstein D. Quantitative mapping of the retinal thickness in diabetic eyes with clincally significant macular edema.Invest. Ophthalmol. Vis. Sci.38(Suppl.), S342 (1997).
  • Neubauer A, Welge-Luben U, Thiel M et al. Tele-screening for diabetic retinopathy with the retinal thickness analyzer.Diabetes Care26, 2890–2897 (2003).
  • Ang A, Tong L, Vernon SA. Improvement of reproducibility of macular volume measurements using the Heidelberg retinal tomography.Br. J. Ophthalmol.84, 1194–1197 (2000).
  • Adams A. Chromatic and luminosity processing in retinal disease.Am. J. Optom. Physiol. Optics59, 954–960 (1982).
  • Sinclair SH, Alaniz R, Presti P. Laser treatment of diabetic macular edema: comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing.Semin. Ophthalmol.14, 214–222 (1999).
  • Howes S, Caelli T, Mitchell P. Contrast sensitivity in diabetics with retinopathy and cataract.Aust. J. Ophthalmol.10, 173–178 (1982).
  • Remky A, Arend O, Hendricks S. Short-wavelength automated perimetry and capillary density in early diabetic maculopathy.Invest. Ophthalmol. Vis. Sci.41, 274–281 (2000).
  • Hudson C, Flanagan J, Turner G et al. Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema.Diabetologia41, 918–928 (1998).
  • Sinclair SH, DelVecchio C. The internist’s role in the management of diabetic retinopathy: I screening and early detection.Cleve. Clin. J. Med.71(2), 151–159 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.